UNASSIGNED: 50 Background: @entity1 experience and local and international clinical research have focused attention on transitions in @entity5 care from treatment to follow-up. Deficiencies in the quality of survivorship care, including necessary testing, have been demonstrated. The Canadian Partnership Against @entity5 has funded projects designed to enhance the implementation of survivorship care plans (SCPs) and to improve @entity5 system-primary care coordination. CancerCare Manitoba, a provincial agency, is a leader in this work. METHODS: The Moving Forward After @entity5 initiative combines the generation of standardized written SCPs from the EMR with enhanced @entity1 assessment at the end of curative systemic / radiation therapy. A transition appointment (TA) is provided by the @entity1 's usual oncology providers and includes screening for distress, appropriate referrals, and provision of a personalized treatment summary and SCP to the @entity1 , with copies to the primary care physician and surgeon. The TA often marks the transfer of medical responsibility to the primary care provider (PCP). RESULTS: Transition appointments have been implemented for colorectal (2012), breast (2014), and @entity706 and @entity5 @entity1 (2015). A total of 364 TAs were done in Manitoba in 2014, of which 140 were with @entity14 with breast (stage I - III) @entity1 , about 59% and 35% respectively of eligible @entity1 . This is an increase of 385% from the 75 TAs done in 2013. Other @entity1 outcomes being collected include perceptions of continuity of care, confidence in survivorship information, evaluation of the care plan documents and also PCP and oncology team perceptions. In order to support practice change, a workflow solution led by a designated team that is adaptable by all sites across the province has been developed. CONCLUSIONS: The provision of TAs and SCPs is being well adopted in Manitoba. We expect that this intervention willimprove the experience of both @entity1 and health care providers and the quality of care at the time of transition to survivorship. Implementation is underway with other disease site groups with the goal of all @entity1 receiving a TA as they transition into survivorship.

Moving forward after XXXX : Implementation of transition appointments and follow-up care plans in Manitoba.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'Patient'] @entity14 :: ('MESH:D015179', 'Disease') :: ['colorectal (stage II and III) and 224'] @entity5 :: ('MESH:D009369', 'Disease') :: ['gynecologic cancer', 'cancer', 'Cancer'] @entity706 :: ('MESH:D008223', 'Disease') :: ['lymphoma']
@entity5 :: (MESH:D009369,Disease) :: ['cancer']
